S 2770 · in committee · major

Share the Savings with Seniors Act

What this bill does

The bill limits how much Medicare patients must pay out-of-pocket for chronic care drugs like blood glucose regulators and anticoagulants.
Medicare prescription drug benefit users with chronic conditions are affected by these cost-sharing changes.
The bill caps copayments at the drug's net negotiated price and ties percentage-based costs to that net price.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

01
How would capping copayments at a drug's net negotiated price affect pharmaceutical companies' pricing strategies and drug development incentives?
02
Which seniors with chronic conditions would benefit most from these out-of-pocket cost limits, and how might affordability differ across income levels?
03
What evidence exists that lower copayment costs for chronic drugs reduces hospitalizations and improves health outcomes enough to offset any Medicare spending increases?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.